Malcolm Boyce Selected Research

Inflammation (Inflammations)

12/2013	The gastrin receptor antagonist netazepide (YF476) prevents oxyntic mucosal inflammation induced by Helicobacter pylori infection in Mongolian gerbils.
10/2005	Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Malcolm Boyce Research Topics

Disease

4	Atrophic Gastritis 01/2024 - 01/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 05/2015
4	Asthma (Bronchial Asthma) 09/2018 - 10/2005
3	Neoplasms (Cancer) 01/2024 - 01/2016
3	Infections 01/2023 - 12/2013
2	Human Influenza (Influenza) 01/2019 - 01/2018
2	Dyspepsia (Indigestion) 02/2017 - 05/2015
2	Hyperplasia 02/2017 - 05/2015
2	Achlorhydria (Hypochlorhydria) 01/2017 - 01/2013
2	Inflammation (Inflammations) 12/2013 - 10/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2024
1	Hyperalgesia 01/2024
1	Wounds and Injuries (Trauma) 01/2024
1	Polycythemia Vera 01/2023
1	beta-Thalassemia (Cooley's Anemia) 01/2023
1	Pulmonary Arterial Hypertension 01/2023
1	COVID-19 01/2023
1	Anemia 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Hot Flashes 12/2020
1	Rheumatoid Arthritis 11/2020
1	Injection Site Reaction 01/2017
1	Alcoholism (Alcohol Abuse) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016
1	Multiple Sclerosis 02/2016
1	Adenocarcinoma 01/2016
1	Rare Diseases (Rare Disease) 05/2015
1	Carcinoid Tumor (Carcinoid) 05/2015
1	Gastritis 12/2013
1	Tetanus 08/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2013
1	Stomach Ulcer (Gastric Ulcer) 01/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2012
1	Respiratory Insufficiency (Respiratory Failure) 08/2011
1	Migraine Disorders (Migraine) 01/2009
1	Obesity 04/2008

Drug/Important Bio-Agent (IBA)

10	YF 476IBA 01/2024 - 01/2013
8	GastrinsIBA 02/2017 - 01/2013
4	Cholecystokinin B ReceptorIBA 01/2017 - 01/2013
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
2	EndonucleasesIBA 01/2019 - 01/2018
2	sfericaseIBA 01/2019 - 01/2018
2	Esomeprazole (Nexium)FDA Link 02/2017 - 01/2013
2	Chromogranin AIBA 01/2017 - 05/2015
2	Hormones (Hormone)IBA 01/2016 - 01/2013
2	AllergensIBA 06/2012 - 10/2005
1	Cholecystokinin (Pancreozymin)IBA 01/2024
1	Vincristine (Oncovin)FDA LinkGeneric 01/2024
1	AlkaloidsIBA 01/2024
1	ensovibepIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2023
1	AcetylgalactosamineIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	N,N-Dimethyltryptamine (Dimethyltryptamine)IBA 01/2023
1	Hallucinogens (Psychedelics)IBA 01/2023
1	IronIBA 01/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2020
1	Adalimumab (Humira)FDA Link 11/2020
1	FKB327IBA 11/2020
1	Biosimilar PharmaceuticalsIBA 11/2020
1	AntigensIBA 09/2018
1	PowdersIBA 09/2018
1	Immunoglobulin FragmentsIBA 09/2018
1	Interleukin-13IBA 09/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2018
1	Monoclonal AntibodiesIBA 09/2018
1	ProdrugsIBA 01/2018
1	Proton Pump InhibitorsIBA 02/2017
1	revusiranIBA 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017
1	nalmefene (Revex)FDA Link 01/2017
1	Z-360IBA 12/2016
1	Interferon beta-1a FDA Link 02/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Pentagastrin (Peptavlon)FDA Link 05/2015
1	Rabeprazole (Aciphex)FDA Link 05/2015
1	Immunoglobulin G (IgG)IBA 08/2013
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 08/2013
1	AntibodiesIBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	3- (3- tert- butylsulfanyl- 1- (4- (6- ethoxypyridin- 3- yl)benzyl)- 5- (5- methylpyridin- 2- ylmethoxy)- 1H- indol- 2- yl)- 2,2- dimethylpropionic acidIBA 01/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2013
1	Diclofenac (SR 38)FDA LinkGeneric 01/2013
1	GhrelinIBA 01/2013
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2013
1	vilanterolIBA 06/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2012
1	fluticasone furoate FDA Link 06/2012
1	Opioid Analgesics (Opioids)IBA 08/2011
1	frovatriptan (Allegro)FDA Link 01/2009
1	CannabinoidsIBA 04/2008
1	N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA 04/2008
1	3- (N- (3,4- dimethoxybenzyl)- 2- (2- (3- methoxy- 4- (3- o- tolylureido)phenyl)acetylamino)acetamido)propanoic acidIBA 10/2005

Therapy/Procedure

2	Therapeutics 02/2017 - 06/2012
1	Intraperitoneal Injections 01/2024
1	Drug Therapy (Chemotherapy) 01/2024
1	Aftercare (After-Treatment) 05/2015